- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Scottish Statutory Instruments
Food
Made
18th May 2022
Laid before the Scottish Parliament
20th May 2022
Coming into force
for the purpose of regulation 1(2)
18th June 2022
for the purpose of regulation 1(3)
30th June 2022
The Scottish Ministers make these Regulations in exercise of the powers conferred by Articles 12(1)(1) and 32A(3) of Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods, amending Regulation (EU) No. 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No. 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No. 1852/2001(2), Article 11(4) of Regulation (EC) No. 2065/2003 of the European Parliament and of the Council on smoke flavourings used or intended for use in or on foods(3), and all other powers enabling them to do so.
There has been consultation as required by Article 9 of Regulation (EC) No. 178/2002 of the European Parliament and of the Council laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety(4).
1.—(1) These Regulations may be cited as the Novel Foods (Authorisations) and Smoke Flavourings (Modification of Authorisations) (Scotland) Regulations 2022 and come into force in accordance with paragraphs (2) and (3).
(2) Regulations 1, 2 and 4 come into force on 18 June 2022.
(3) Regulation 3 comes into force on 30 June 2022.
(4) These Regulations extend to Scotland only.
2.—(1) In these Regulations—
“Regulation (EU) 1321/2013” means Commission Implementing Regulation (EU) No. 1321/2013 establishing the Union list of authorised smoke flavouring primary products for use as such in or on foods and/or for the production of derived smoke flavourings(5), and
“Regulation (EU) 2017/2470” means Commission Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods(6).
(2) Unless the contrary intention appears, any expression used both in these Regulations and in Regulation (EU) 1321/2013 or Regulation (EU) 2017/2470 has the same meaning as it bears in those Regulations.
3. The list of authorised novel foods set out in the Annex to Regulation (EU) 2017/2470 is amended in accordance with schedules 1 to 5.
4.—(1) The list of authorised smoke flavouring primary products set out in the Annex to Regulation (EU) 1321/2013 is amended in accordance with paragraphs (2) to (5).
(2) In the entry for Scansmoke PB 1110 for—
(a)“Azelis Denmark A/S” substitute “proFagus GmbH”, and
(b)“Lundtoftegaardsvej 95, 2800, Lyngby, DENMARK” substitute “Uslarer Strasse 30, 37194 Bodenfelde, GERMANY”.
(3) In the entry for Zesti Smoke Code 10 for—
(a)“Mastertaste” substitute “Kerry Group Plc”, and
(b)“Draycott Mills, Cam, Dursley, Gloucestershire, GL11 5NA, UNITED KINGDOM” substitute “Prince’s Street, Tralee, Co. Kerry, V92 EH11, IRELAND”.
(4) In the entries for SmokeEz C-10 and SmokeEz Enviro-23 for—
(a)“Red Arrow Products Company LLC” substitute “Kerry Group Plc”, and
(b)“P.O. Box 1537, 633 South 20th street, Manitowoc, WI 54221-1537, USA” substitute “Prince’s Street, Tralee, Co. Kerry, V92 EH11, IRELAND”.
(5) In the entry for Tradismoke™ A MAX for—
(a)“Nactis” substitute “J. Rettenmaier & Söhne GmbH + CO KG”, and
(b)“36, rue Gutenberg - ZI La Marinière, 91070 Bondoufle, FRANCE” substitute “Holzmühle 1, 73494 Rosenberg, GERMANY”.
MAREE TODD
Authorised to sign by the Scottish Ministers
St Andrew’s House,
Edinburgh
18th May 2022
Regulation 3
1. In the entry for 2’-Fucosyllactose/Difucosyllactose mixture (‘2’-FL/DFL’) (microbial source) in Table 1 (authorised novel foods) insert at the end the following condition of use—
| “Specified food category | Maximum levels | ||||
| Milk-based drinks and similar products intended for young children | 1.2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer” |
2. For the entry for 2’-Fucosyllactose/Difucosyllactose mixture (‘2’-FL/DFL’) (microbial source) in Table 2 (specifications) substitute the following—
| “2’-Fucosyllactose /Difucosyllactose mixture (‘2’-FL/DFL’) (microbial source) | Description/Definition: |
| 2’-Fucosyllactose/Difucosyllactose mixture is a purified, white to off-white powder or agglomerates thereof that is produced by a microbial process. | |
| Source: Genetically modified strain of Escherichia coli strain K-12 DH1 | |
| Characteristics/Composition: | |
Appearance: White to off-white powder or agglomerates Sum of 2’-Fucosyllactose, Difucosyllactose, D-Lactose, L-Fucose, and 3-Fucosyllactose (% of dry matter): ≥ 92.0 % (w/w) Sum of 2’-fucosyllactose and difucosyllactose (% of dry matter): ≥ 85.0 % (w/w) 2’-Fucosyllactose (% of dry matter): ≥ 75.0 % (w/w) Difucosyllactose (% of dry matter): ≥ 5.0 % (w/w) D-Lactose: ≤ 10.0 % (w/w) L-Fucose: ≤ 1.0 % (w/w) 2’-Fucosyl-D-lactulose: ≤ 2.0 % (w/w) Sum of other carbohydrates(7): ≤ 6.0 % (w/w) Moisture: ≤ 6.0 % (w/w) Ash, sulfated: ≤ 0.8 % (w/w) pH (20 °C, 5 % solution): 4.0-6.0 Residual protein: ≤ 0.01 % (w/w) | |
| Microbiological criteria: | |
Aerobic mesophilic bacteria total plate count: ≤ 1000 CFU/g Enterobacteriaceae: ≤ 10 CFU/g Salmonella sp.: Negative/25 g Yeast: ≤ 100 CFU/g Mould: ≤ 100 CFU/g Residual endotoxins: ≤ 10 EU/mg CFU: Colony Forming Units; EU: Endotoxin Units” |
Regulation 3
1. In Table 1 (authorised novel foods), after the entry for Schizochytrium sp. (ATCC PTA-9695) oil insert the following entry—
| “Schizochytrium sp. (FCC-3204) oil | Specified food category | Maximum levels of DHA | |||
| Food supplements as defined in the Food Supplements (Scotland) Regulations 2003(8) excluding food supplements for infants and children under 3 years of age | 1 g/day | The designation of the novel food on the labelling of the foodstuffs containing it is “Oil from the microalgae Schizochytrium sp.”. | |||
| Infant formula and follow-on formula as defined in Regulation (EU) 609/2013(9) | In accordance with Regulation (EU) 609/2013 | The labelling of food supplements containing Schizochytrium sp. (FCC-3204) oil must bear a statement that they should not be consumed by infants and children under 3 years of age.” |
2. In Table 2 (specifications), after the entry for Schizochytrium sp. (ATCC PTA-9695) oil insert the following entry–
| “Schizochytrium sp. (FCC-3204) oil | Description/Definition: |
| The novel food is an oil produced from the strain FCC-3204 of the microalgae Schizochytrium sp. | |
| Composition: | |
Acid value: ≤ 0.5 mg KOH (potassium hydroxide)/g Peroxide value (PV): ≤ 5.0 meq (milliequivalent)/kg oil Moisture and volatiles: ≤ 0.05 % Unsaponifiables: ≤ 4.5 % Trans-fatty acids: ≤ 1.0 % Docosahexaenoic acid (DHA): ≥ 32.0 % p-anisidine value: ≤ 10” |
Regulation 3
1. In Table 1 (authorised novel foods), after the entry for Schizochytrium sp. (T18) oil insert the following entry—
| “Schizochytrium sp. (WZU477) oil | Specified food category | Maximum levels of DHA | The designation of the novel food on the labelling of the foodstuffs containing it is “Oil from the microalgae Schizochytrium sp.”. | Included in the list on 30 June 2022. | |
| Infant formula and follow-on formula as defined in Regulation (EU) 609/2013 | In accordance with Regulation (EU) 609/2013 | ||||
| This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. | |||||
| Applicant: Progress Biotech BV of Canaalstaete, Kanaalweg 33, 2903LR Capelle aan den Ijssel, the Netherlands. | |||||
| During the period of data protection, the novel food Schizochytrium sp. (WZU477) oil is authorised for placing on the market within Scotland only by Progress Biotech BV unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Progress Biotech BV. | |||||
| The data protection will expire at the end of 29 June 2027.” |
2. In Table 2 (specifications), after the entry for Schizochytrium sp. (T18) oil insert the following entry—
| “Schizochytrium sp. (WZU477) oil | Description/Definition: The novel food is an oil produced from the strain WZU477 of the microalgae Schizochytrium sp. |
| Composition: | |
Acid value: ≤ 0.5 mg KOH (potassium hydroxide)/g Peroxide value (PV): ≤ 5.0 meq (milliequivalent)/kg oil Moisture and volatiles: ≤ 0.05 % Unsaponifiables: ≤ 4.5 % Trans-fatty acids: ≤ 1.0 % Docosahexaenoic acid (DHA): ≥ 32.0 % p-anisidine value: ≤ 10” |
Regulation 3
1. In Table 1 (authorised novel foods), after the entry for Selenium-containing yeast (Yarrowia lipolytica) biomass insert the following entry—
| “3’-Sialyllactose (3’-SL) sodium salt (microbial source) | Specified food category | Maximum levels (expressed as 3’- Sialyllactose) | The designation of the novel food on the labelling of the foodstuffs containing it is “3’-Sialyllactose sodium salt”. | Included in the list on 30 June 2022. | |
| Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products | 0.25 g/L | This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. | |||
| Flavoured fermented milk-based products including heat-treated products | 0.25 g/L (beverages) | The labelling of food supplements containing 3’-Sialyllactose sodium salt must bear a statement that they should not be consumed: a) if foods containing added 3’-Sialyllactose sodium salt are consumed the same day, b) by infants and young children. | |||
| 2.5 g/kg (products other than beverages) | Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. | ||||
| Unflavoured fermented milk-based products | 0.25 g/L (beverages) | During the period of data protection, the novel food 3’-sialyllactose sodium salt is authorised for placing on the market within Scotland only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S. | |||
| 0.5 g/kg (products other than beverages) | |||||
| Beverages (flavoured drinks, excluding drinks with a pH less than 5) | 0.25 g/L | ||||
| Cereal bars | 2.5 g/kg | ||||
| Infant formula as defined in Regulation (EU) 609/2013 | 0.2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
| Follow-on formula as defined in Regulation (EU) 609/2013 | 0.15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
| The data protection will expire at the end of 29 June 2027. | |||||
| Processed cereal-based food and baby food for infants and young children as defined in Regulation (EU) 609/2013 | 0.15 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
| 1.25 g/kg for products other than beverages | |||||
| Milk-based drinks and similar products intended for young children | 0.15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
| Total diet replacement foods for weight control as defined in Regulation (EU) 609/2013 | 0.5 g/L (beverages) | ||||
| 5 g/kg (products other than beverages) | |||||
| Food for special medical purposes as defined in Regulation (EU) 609/2013 | In accordance with the particular nutritional requirements of the persons for whom the products are intended | ||||
| Food supplements as defined in the Food Supplements (Scotland) Regulations 2003, excluding food supplements for infants and young children | 0.5 g/day.” |
2. In Table 2 (specifications), after the entry for Selenium-containing yeast (Yarrowia lipolytica) biomass insert the following entry—
| “3’‐Sialyllactose (3’‐SL) sodium salt (microbial source) | Description: |
| 3’-Sialyllactose (3’-SL) sodium salt is a purified, white to off-white powder or agglomerate that is produced by a microbial process and contains limited levels of lactose, 3’-sialyl-lactulose, and sialic acid. | |
| Source: Genetically modified strain of Escherichia coli K-12 DH1. | |
| Definition: | |
Chemical formula: C23H38NO19Na Chemical name: N-Acetyl-α-D-neuraminyl-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucose, sodium salt Molecular mass: 655.53 Da CAS No 128596-80-5 | |
| Characteristics/Composition: | |
Appearance: White to off-white powder or agglomerate Sum of 3’-Sialyllactose sodium salt, D-Lactose, and Sialic acid (% of dry matter): ≥ 90.0 % (w/w) 3’-Sialyllactose sodium salt (% of dry matter): ≥ 88.0 % (w/w) D-Lactose: ≤ 5.0 % (w/w) Sialic acid: ≤ 1.5 % (w/w) 3’-Sialyl-lactulose: ≤ 5.0 % (w/w) Sum of other carbohydrates: ≤ 3.0 % (w/w) Moisture: ≤ 8.0 % (w/w) Sodium: 2.5 – 4.5 % (w/w) Chloride: ≤ 1.0 % (w/w) pH (20 °C, 5 % solution): 4.5 -6.0 Residual protein: ≤ 0.01 % (w/w). | |
| Microbiological criteria: | |
Aerobic mesophilic bacteria total plate count: ≤ 1000 CFU/g Enterobacteriaceae: ≤ 10 CFU/g Salmonella sp.: Absence in 25 g Yeast: ≤ 100 CFU/g Mould: ≤ 100 CFU/g Residual endotoxins: ≤ 10 EU/mg CFU: Colony Forming Units; EU: Endotoxin Units” |
Regulation 3
1. In Table 1 (authorised novel foods), after the entry for 3’Sialyllactose (3’-SL) sodium salt (microbial source)(10) insert the following entry—
| “6’-Sialyllactose (6’-SL) sodium salt (microbial source) | Specified food category | Maximum levels (expressed as 6’-Sialyllactose) | The designation of the novel food on the labelling of the foodstuffs containing it is “6’-Sialyllactose sodium salt”. | Included in the list on 30 June 2022. | |
| Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products | 0.5 g/L | This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. | |||
The labelling of food supplements containing 6’-Sialyllactose (6’-SL) sodium salt must bear a statement that they should not be consumed: (a) if foods containing added 6’-Sialyllactose sodium salt are consumed on the same day, (b) by infants and young children. | |||||
| Unflavoured fermented milk-based products | 0.5 g/L (beverages) | ||||
| 2.5 g/kg (products other than beverages) | |||||
| Flavoured fermented milk-based products including heat-treated products | 0.5 g/L (beverages) | Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. | |||
| 5.0 g/kg (products other than beverages) | |||||
| During the period of data protection, the novel food 6’-sialyllactose sodium salt is authorised for placing on the market within Scotland only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S. | |||||
| Beverages (flavoured drinks, excluding drinks with a pH less than 5) | 0.5 g/L | ||||
| Cereal bars | 5.0 g/kg | ||||
| Infant formula as defined in Regulation (EU) 609/2013 | 0.4 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
| Follow-on formula as defined in Regulation (EU) 609/2013 | 0.3 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
| Processed cereal-based food and baby food for infants and young children as defined in Regulation (EU) 609/2013 | 0.3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | The data protection will expire at the end of 29 June 2027. | |||
| 2.5 g/kg for products other than beverages | |||||
| Milk based drinks and similar products intended for young children | 0.3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer | ||||
| Total diet replacement foods for weight control as defined in Regulation (EU) 609/2013 | 1.0 g/L (beverages) | ||||
| 10.0 g/kg (products other than beverages) | |||||
| Food for special medical purposes as defined in Regulation (EU) 609/2013 | In accordance with the particular nutritional requirements of the persons for whom the products are intended | ||||
| Food supplements as defined in the Food Supplements (Scotland) Regulations 2003, excluding food supplements for infants and young children | 1.0 g/day.” |
2. In Table 2 (specifications), after the entry for 3’Sialyllactose (3’-SL) sodium salt (microbial source) insert the following entry—
| “6′‐Sialyllactose (6′‐SL) sodium salt (microbial source) | Description: |
| 6’-Sialyllactose (6’-SL) sodium salt is a purified, white to off-white powder or agglomerate that is produced by a microbial process and contains limited levels of lactose, 6’-sialyl-lactulose, and sialic acid. | |
| Source: Genetically modified strain of Escherichia coli K-12 DH1. | |
| Definition: | |
Chemical formula: C23H38NO19Na Chemical name: N-Acetyl-α-D-neuraminyl-(2→6)-β-D-galactopyranosyl-(1→4)-D-glucose, sodium salt Molecular mass: 655.53 Da CAS No 157574-76-0 | |
| Characteristics/Composition: | |
Appearance: White to off-white powder or agglomerate Sum of 6’-Sialyllactose sodium salt, D-Lactose and Sialic acid (% of dry matter): ≥ 94.0 % (w/w) 6’-Sialyllactose sodium salt (% of dry matter): ≥ 90.0 % (w/w) D-Lactose: ≤ 5.0 % (w/w) Sialic acid: ≤ 2.0 % (w/w) 6’-Sialyl-lactulose: ≤ 3.0 % (w/w) Sum of other carbohydrates: ≤ 3.0 % (w/w) Moisture: ≤ 6.0 % (w/w) Sodium: 2.5-4.5 % (w/w) Chloride: ≤ 1.0 % (w/w) pH (20 °C, 5 % solution): 4.5-6.0 Residual protein: ≤ 0.01 % (w/w) | |
| Microbiological criteria: | |
Aerobic mesophilic bacteria total plate count: ≤ 1 000 CFU/g Enterobacteriaceae: ≤ 10 CFU/g Salmonella sp.: Absence in 25 g Yeast: ≤ 100 CFU/g Mould: ≤ 100 CFU/g Residual endotoxins: ≤ 10 EU/mg CFU: Colony Forming Units; EU: Endotoxin Units” |
(This note is not part of the Regulations)
These Regulations make provision as regards the authorisation of novel foods under Regulation (EU) 2015/2283, and also substitute new authorisation holders for smoke flavourings already authorised under Regulation (EC) 2065/2003.
Regulation 3 and schedule 1 make changes to the conditions of use and specifications of a novel food already authorised under Regulation (EU) 2015/2283, 2’-Fucosyllactose/Difucosyllactose (2’FL/DFL).
Regulation 3 and schedules 2 to 5 authorise the placing on the market in Scotland of four novel foods by updating the list of novel foods (set out in Regulation (EU) 2017/2470) to add—
(a)Schizochytrium sp. (FCC-3204) oil,
(b)Schizochytrium sp. (WZU477) oil,
(c)3’-Sialyllactose (3’-SL) sodium salt, and
(d)6’-Sialyllactose (6’-SL) sodium salt.
Regulation 4 substitutes new authorisation holders for five smoke flavourings already authorised under Regulation (EC) 2065/2003—
(a)Scansmoke PB 1110,
(b)Zesti Smoke Code 10,
(c)SmokeEz C-10,
(d)SmokeEz Enviro-23, and
(e)Tradismoke™ A MAX.
Article 9 makes provision as regards how the regulation-making power in Article 12(1) is to be exercised and Article 27(1) lays down requirements as regards the information to be included in the entry for a novel food on the list set out in Regulation (EU) 2017/2470 where it is authorised based on proprietary scientific evidence or scientific data.
EUR 2015/2283 as amended by S.I. 2019/702. The terms “prescribe” and “appropriate authority” are defined in Article 3.
EUR 2065/2003 as amended by S.I. 2019/860. The terms “prescribe” and “appropriate authority” are defined in Article 3.
EUR 178/2002 as amended by S.I. 2019/641.
EUR 1321/2013 as amended by S.I. 2019/860.
EUR 2017/2470 as amended by S.I. 2019/702.
2′-Fucosyl-galactose, Glucose, Galactose, Mannitol, Sorbitol, Galactitol, Trihexose, Allo-lactose and other structurally related carbohydrates.
S.S.I. 2003/278, as relevantly amended by S.S.I. 2019/54.
EUR 609/2013 as amended by S.I. 2019/651.
Inserted by S.S.I. 2022/168.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Policy Note sets out a brief statement of the purpose of a Scottish Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Scottish Statutory Instrument accessible to readers who are not legally qualified and accompany any Scottish Statutory Instrument or Draft Scottish Statutory Instrument laid before the Scottish Parliament from July 2012 onwards. Prior to this date these type of notes existed as ‘Executive Notes’ and accompanied Scottish Statutory Instruments from July 2005 until July 2012.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: